PENTOKEY ORGANY (INDIA) LTD. Share Price

BSE: 524210

S Cap

₹ 34.00

+₹1.68 (5.20%)

Last updated 03 Sep, 2026, 12:08 IST

PENTOKEY ORGANY (INDIA) LTD. Share Price Today

As of 3 Sep 2026, PENTOKEY ORGANY (INDIA) LTD. share price is ₹34.00. The stock opened at ₹32.58, compared to its previous close of ₹32.32. During today's trading session, PENTOKEY ORGANY (INDIA) LTD. share price moved in the range of ₹32.32 to ₹34.00, with an average price of ₹33.16 for the day. Looking at its last 52-week, the stock has touched a low of ₹28.49 and a high of ₹57.00.

₹32.32

5.20% up today

₹34.00

1D LOW

1D HIGH

Stock Performance

UnderperformingUnderperforming Nifty by 18.36 % in last 1 yr

PENTOKEY ORGANY (INDIA) LTD. Returns Calculator

If you would've invested

₹

₹1,000₹1Cr

Historical Returns

1 Year

₹3,92,428-₹1,07,572 (-21.51%)

3 Year

₹3,28,947-₹1,71,053 (-34.21%)

5 Year

₹7,92,541+₹2,92,541 (+58.51%)

₹25.86₹38.78

Circuit Low

Circuit High

₹28.49₹57.00

52-Week Low

52-Week High

Circuit

₹25.86

₹38.78

52-week

₹28.49

₹57.00

About PENTOKEY ORGANY (INDIA) LTD.

ISIN

INE702E01015

Sector Market Cap

₹ 20.26 Cr

Pentokey Organy (India) Limited is an India-based company, which is engaged in the trading of pharmaceutical products. The Company operates through a single segment, which is Pharma.

PENTOKEY ORGANY (INDIA) LTD. Financial Highlights

Revenue: PENTOKEY ORGANY (INDIA) LTD. reported revenue of ₹1.29 crore in FY26 vs ₹1.29 crore in FY25. It showed an increase of 0.00% on a yearly basis.
Operating Profit: PENTOKEY ORGANY (INDIA) LTD. reported an operating profit of ₹0.25 crore in FY26 vs ₹0.25 crore in FY25. It showed an increase of 0.00% on a year-on-year basis.
Net Profit: PENTOKEY ORGANY (INDIA) LTD. reported a net profit of ₹0.25 crore in FY26 vs ₹0.25 crore in FY25. It showed an increase of 0.00% on a yearly basis.

PENTOKEY ORGANY (INDIA) LTD. Quarterly Result Highlights

PENTOKEY ORGANY (INDIA) LTD. reported revenue of ₹0.08 crore in Jun 2026, compared with ₹2.50 crore in Mar 2026, representing a decrease of 96.80% on a quarter-on-quarter (QoQ) basis.
PENTOKEY ORGANY (INDIA) LTD. reported an operating profit of ₹0.22 crore in Jun 2026, compared with ₹0.20 crore in Mar 2026, representing an increase of 10.00% on a quarter-on-quarter (QoQ) basis.
PENTOKEY ORGANY (INDIA) LTD. reported a profit of ₹0.22 crore in Jun 2026, compared with ₹0.20 crore in Mar 2026, reflecting an increase of 10.00% on a QoQ basis.
The earnings per share (EPS) of PENTOKEY ORGANY (INDIA) LTD. stood at ₹0.39 during Jun 2026.

Know more

Promoters

73.03%

FII

0.00%

Other DII

2.24%

Retail and other

24.66%

Mutual funds

0.06%

Foreign institutions - FII

FII shareholding by period
Sep 2025	0.00%
Dec 2025	0.00%
Mar 2026	0.00%
Jun 2026	0.00%

Mkt Cap Cr

20.26

P/E

75.16

P/B

2.09

ROE

2.53%

D/E

0.00

ROCE

2.56%

Div. Yield

0.00%

EPS(TTM)

0.39

Turnover

0.10

EV/EBITDA

52.58

Net Margin

0.00%

Op. Margin

0.00%

ROA

2.86%

Quick Ratio

0.00

Curr. Ratio

-30.87

Mkt Cap Cr

20.26

P/E

75.16

P/B

2.09

ROE

2.53%

D/E

0.00

ROCE

2.56%

Div. Yield

0.00%

EPS(TTM)

0.39

Turnover

0.10

EV/EBITDA

52.58

Net Margin

0.00%

Op. Margin

0.00%

ROA

2.86%

Quick Ratio

0.00

Curr. Ratio

-30.87

Based on fundamentals, this stock's

Performance

Very Poor

Pentokey Organy has not beaten FD return of 7%

Valuation

Overvalued

Pentokey Organy appears overvalued compared to its peers

Peer Comparison

Peer comparison — key ratios
Name	Mkt Cap Cr	P/E	P/B	ROE	D/E	ROCE	Book Value	Div. Yield	Turnover	EPS(TTM)
Sun Pharmaceutical Industries	4,63,791.00	38.28	5.55	13.74%	0.61	17.33%	93.24	0.83%	0.48	10.90
Divis Laboratories	2,45,081.00	83.79	14.62	15.32%	0.00	19.56%	629.49	0.32%	0.55	98.19
Torrent Pharmaceuticals	1,90,351.00	88.29	22.64	25.49%	1.69	13.85%	222.76	0.68%	0.49	58.70
Zydus Lifesciences	1,14,833.00	25.00	4.24	18.59%	0.31	17.35%	237.30	0.09%	0.33	35.38
Cipla	1,14,163.00	34.02	3.32	11.27%	0.00	14.95%	423.36	0.92%	0.45	43.52
Laurus Labs	1,00,660.00	92.32	18.99	16.77%	0.40	16.14%	97.20	0.11%	0.67	13.72
Lupin	98,431.00	17.73	4.38	23.76%	0.04	24.88%	659.00	0.84%	0.57	129.18
Dr. Reddy's Laboratories	96,906.30	30.44	2.55	11.07%	0.18	12.54%	377.95	0.69%	0.41	38.68
Mankind Pharma	97,467.00	47.54	6.03	11.74%	0.34	13.13%	396.98	0.04%	0.44	49.37
Aurobindo Pharma	95,299.80	25.68	2.52	9.25%	0.19	11.76%	394.82	0.24%	0.38	41.58

PENTOKEY ORGANY (INDIA) LTD. Financials

Full statement

Income Statement · Standalone

Income Statement · Standalone — all values in INR Crore
Particulars	Mar 2025	Mar 2024	Mar 2023	Mar 2022
Revenue	₹0.83	₹4.40	₹4.37	₹0.00
Other Income	₹0.46	₹0.45	₹2.36	₹0.25
Total Revenue	₹1.29	₹4.85	₹6.72	₹0.25
Total Expenses	₹1.05	₹3.97	₹3.55	₹0.42
Profit Before Tax	₹0.25	₹0.88	₹3.18	-₹0.16
Tax	₹0.00	₹0.00	₹0.00	₹0.00
Profit After Tax	₹0.25	₹0.88	₹3.18	-₹0.16
EPS - Basic	₹0.39	₹1.39	₹5.06	-₹0.26
EPS - Diluted	₹0.39	₹1.39	₹5.06	-₹0.26

Cash Flow · Standalone

Cash Flow · Standalone — all values in INR Crore
Particulars	Mar 2025	Mar 2024	Mar 2023	Mar 2022
Profit before tax	₹0.25	₹0.87	₹3.18	-₹0.16
Income before WC changes	-₹0.21	₹0.44	₹2.90	-₹0.38
Change in Assets	₹0.38	₹0.42	-₹3.50	₹0.09
Change in Liabilities	₹0.09	-₹0.30	₹0.49	-₹0.10
Change in WC	₹0.46	₹0.12	-₹3.01	-₹0.01
Cash flow from Operations	₹0.22	₹0.55	-₹0.10	-₹0.42
Cash flow from Investing	-₹0.20	-₹0.59	₹0.19	₹0.23
Cash flow from Financing	₹0.00	-₹0.01	-₹0.03	₹0.00
Total Cash Flow	₹0.01	-₹0.04	₹0.06	-₹0.19
Cash (Start of the year)	₹0.07	₹0.11	₹0.05	₹0.24
Cash (End of the year)	₹0.08	₹0.07	₹0.11	₹0.05

Balance Sheet · Standalone

Balance Sheet · Standalone — all values in INR Crore
Particulars	Mar 2025	Mar 2024	Mar 2023	Mar 2022
Non-Current Assets	₹1.74	₹0.53	₹0.48	₹0.48
Current Assets	₹8.05	₹8.97	₹8.44	₹4.78
Total Assets	₹9.79	₹9.51	₹8.92	₹5.25
Current Liabilities	₹0.33	₹0.24	₹0.54	₹0.05
Net Current Asset	₹7.72	₹8.73	₹7.90	₹4.72
Non-Current Liabilities	₹0.00	₹0.00	₹0.00	₹0.00
Equity Capital	₹9.46	₹9.26	₹8.38	₹5.20
Total Equity & Liabilities	₹9.79	₹9.51	₹8.92	₹5.25